Literature DB >> 35235773

Metabolic programs tailor T cell immunity in viral infection, cancer, and aging.

Sofie Hedlund Møller1, Pei-Chun Hsueh1, Yi-Ru Yu2, Lianjun Zhang3, Ping-Chih Ho4.   

Abstract

Productive T cell responses to infection and cancer rely on coordinated metabolic reprogramming and epigenetic remodeling among the immune cells. In particular, T cell effector and memory differentiation, exhaustion, and senescence/aging are tightly regulated by the metabolism-epigenetics axis. In this review, we summarize recent advances of how metabolic circuits combined with epigenetic changes dictate T cell fate decisions and shape their functional states. We also discuss how the metabolic-epigenetic axis orchestrates T cell exhaustion and explore how physiological factors, such as diet, gut microbiota, and the circadian clock, are integrated in shaping T cell epigenetic modifications and functionality. Furthermore, we summarize key features of the senescent/aged T cells and discuss how to ameliorate vaccination- and COVID-induced T cell dysfunctions by metabolic modulations. An in-depth understanding of the unexplored links between cellular metabolism and epigenetic modifications in various physiological or pathological contexts has the potential to uncover novel therapeutic strategies for fine-tuning T cell immunity.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8; COVID; aging; epigenetic; exhaustion; immunometabolism

Mesh:

Year:  2022        PMID: 35235773     DOI: 10.1016/j.cmet.2022.02.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  2 in total

1.  Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8+ T cell exhaustion.

Authors:  Kaili Ma; Lina Sun; Mingjing Shen; Xin Zhang; Zhen Xiao; Jiajia Wang; Xiaowei Liu; Kanqiu Jiang; F Xiao-Feng Qin; Feng Guo; Baojun Zhang; Lianjun Zhang
Journal:  iScience       Date:  2022-05-04

Review 2.  Advances in the therapeutic application and pharmacological properties of kinsenoside against inflammation and oxidative stress-induced disorders.

Authors:  Li Lu; Yuan Xiong; Ze Lin; Xiangyu Chu; Adriana C Panayi; Yiqiang Hu; Juan Zhou; Bobin Mi; Guohui Liu
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.